United States set
Menu Shopping cart $0 Search
Distributed product

Anti-Gliadin sIgA/IgA ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, HRP-labelled antibody
  • Species:Human
Cat. No. Size Price

Discount IC6300 96 wells (1 kit) $640
PubMed Product Details
Technical Data


Sandwich ELISA, HRP-labelled antibody




Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Limit of Detection

2.1 mU/g

Intra-assay (Within-Run)

n = 10; CV = 3.8%

Inter-assay (Run-to-Run)

n = 10; CV = 9.1%

Spiking Recovery


Dilution Linearity




  • European Union: for in vitro diagnostic use
  • rest of the world: for research use only!
  • The kit measures anti-gliadin sIgA/IgA in human stool.
  • Assay format is 96 wells
  • Components of the kit are provided ready to use or concentrated

Research topic

Diabetology - Autoimmunity


Applications: Food intolerance, Monitoring of an elimination diet. Celiac disease is a chronic illness of the small intestinal mucous membrane. The reason is an intolerance against gluten, which is found in many cereals. The intake of gluten-containing food leads to an inflammation of the small intestinal mucous membrane. The resorption of nutrients is reduced. The symptoms of the disease are reduction of weight, diarrhoea, vomitus, anorexia and tiredness. The growth of children is reduced. The characteristic of the symptoms might be different. The only therapeutic treatment is a gluten-free diet. A non-treated celiac disease increases the risk of non-Hodgkin-lymphoma and colon cancer. In five to ten percent of the patients celiac disease is associated with diabetes mellitus type 1. Women are more often affected than men. The outcome of the disease is pronounced during infancy and in an age between 30 and 40 years.

Related Products Docs